BEAM
Beam Therapeutics Inc.
NASDAQHealthcareBiotechnologyUS
USD27.29
+0.96 (+3.65%)
Rating:C-
Company Profile
CEO
John Evans
IPO Date
2020-02-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$26.50
Prev. Close
$26.33
Day Low
$26.10
Day High
$27.77
52W Low
$15.60
52W High
$38.26
Market Cap
$2.81B
Volume
1.83M